On November 3, 2026, a significant development emerged from the regulatory filings of the Canary Staked INJ ETF.
Canary filed Form 8-A with the SEC, registering the ETF shares under Section 12(b) of the Securities Exchange Act of 1934.
And here is the most important part:
NASDAQ HAS APPROVED THE APPLICATION TO LIST THE CANARY STAKED INJ ETF!
Expected ticker: INJC
This is no longer just an ETF rumor. It is a real regulatory milestone in Injective’s journey toward entering the traditional U.S. financial markets.
1. NASDAQ’S LISTING APPROVAL – WHY IS THIS SUCH AN IMPORTANT MILESTONE?
The Injective community has been waiting for an INJ ETF for a long time.
We have witnessed:
The initial ETF filing.
Multiple S-1/A amendments.
Canary continuing to refine the fund’s structure.
The regulatory process gradually moving forward.
And now, Form 8-A confirms that Nasdaq has approved the application to list the ETF shares.
This is a significant step forward.
Nasdaq’s approval indicates that the ETF has cleared an important milestone in the process of preparing its shares for exchange trading.
INJ is moving closer to the gateway of traditional financial markets.
2. CANARY STAKED INJ ETF – MORE THAN JUST A PRICE-TRACKING ETF
One distinctive feature of the Canary Staked INJ ETF is its proposed structure, which directly holds INJ and participates in staking.
According to the prospectus:
🔹 The ETF aims to provide exposure to the price of INJ.
🔹 The fund may stake a large portion of its INJ holdings.
🔹 Investors could gain exposure to INJ through traditional brokerage accounts.
🔹 The creation of new ETF shares could generate actual demand for INJ when fresh capital enters the fund.
This is what makes the ETF particularly interesting from an Injective tokenomics perspective.
If the fund attracts net inflows, demand for INJ could increase.
And if the INJ acquired by the fund is subsequently staked, a portion of the circulating supply could become locked in staking.
However, the actual impact will depend on the ETF’s capital flows after launch.
3. WHAT COULD THIS CHANGE FOR INJ?
In my view, the biggest impact of an ETF is not just its short-term price reaction.
If the INJ ETF officially launches and attracts capital, Injective could benefit from:
🔹 Access to capital from traditional investors.
🔹 Greater visibility in the U.S. financial markets.
🔹 Potential demand for INJ through ETF share creation.
🔹 Increased attention from institutional investors.
🔹 A new catalyst for the RWA narrative and bringing traditional finance on-chain.
In particular, for a project focused on real-world asset tokenization and on-chain financial applications, an ETF could expand its potential investor base.
But we also need to remain realistic:
An ETF does not automatically make INJ’s price rise. Actual capital flows will be the key factor.
4. BTCVN4’S PERSPECTIVE
Honestly, this is one of the milestones the INJ community has been waiting for over a long period.
I believe an ETF could become an important long-term catalyst for Injective.
However, I will not make an investment decision based solely on Nasdaq’s listing approval.
I will be watching:
The official ETF trading date.
Fund inflows during the first few days.
The actual amount of INJ held by the fund.
INJ’s price reaction and the broader crypto market.
If the ETF launches and attracts sustainable capital inflows, that could be the factor that significantly changes INJ’s supply-demand dynamics.
CONCLUSION
NASDAQ HAS APPROVED THE LISTING OF THE CANARY STAKED INJ ETF – A SIGNIFICANT STEP FORWARD IN INJ’S ETF JOURNEY!
The November 3, 2026, Form 8-A filing marks an important development.
From an initial ETF filing, through multiple amendments, to Nasdaq’s approval of the listing application.
Injective is moving closer to gaining access to the traditional U.S. financial markets.
I will continue monitoring updates from the SEC, Canary Capital, and Nasdaq.
The INJ ETF may be approaching its trading debut. But the most important factor will still be actual capital flows after the ETF launches.
What do you think about this milestone? Could the ETF become a catalyst for a new growth cycle for Injective?
$INJ #injective #BTCVN4 #crypto #RWA #BinanceSquare
— BTCVN4
